Curis
CRIS
#11190
Rank
A$2.32 M
Marketcap
A$0.96
Share price
-5.38%
Change (1 day)
-61.37%
Change (1 year)

Earnings for Curis (CRIS)

Earnings in 2026 (TTM): -A$11.74 Million

According to Curis's latest financial reports the company's current earnings are A$4.31 Million. In 2025 the company made an earning of -A$7.73 Million, an increase over its 2024 earnings that were of -A$61.22 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Curis from 2001 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$11.74 Million51.93%
2025 -A$7.73 Million-87.38%
2024 -A$61.22 Million-5.77%
2023 -A$64.97 Million-13.1%
2022 -A$74.76 Million27.52%
2021 -A$58.63 Million65.09%
2020 -A$35.51 Million-9.1%
2019 -A$39.07 Million-4.73%
2018 -A$41.01 Million-41.95%
2017 -A$70.63 Million-14.37%
2016 -A$82.49 Million3.55%
2015 -A$79.65 Million271.52%
2014 -A$21.44 Million76.64%
2013 -A$12.14 Million
2011 -A$10.31 Million27.76%
2010 -A$8.07 Million-43.87%
2009 -A$14.38 Million-23.44%
2008 -A$18.78 Million56.66%
2007 -A$11.99 Million-16.71%
2006 -A$14.39 Million-36.92%
2005 -A$22.82 Million156.25%
2004 -A$8.91 Million-37.24%
2003 -A$14.19 Million-93.34%
2002 -A$0.22 Billion86.79%
2001 -A$0.12 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$9.88 B-81,859.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$17.04 B-141,080.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-A$88.56 Million 632.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
A$1.48 B-12,356.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-A$0.47 Billion 3,756.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-A$31.86 Million 163.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-A$0.14 Billion 1,025.71%๐Ÿ‡บ๐Ÿ‡ธ USA